Doctors raise alarm over pentavalent vaccine drive

Three deaths in Kerala in three weeks caused the alarm

Image
Sreelatha Menon
Last Updated : Jan 29 2013 | 2:34 PM IST

Doctors have raised an alarm over safety of Pentavalent vaccines for children introduced in two states and have asked the Health Ministry to immediately put a halt on the programme.

A single dose of the vaccine provides immunity against five diseases viz hepatitis B, diphtheria, pertussis, tetnus and hib disease a new addition to the routine immunization programme.

They have questioned the inclusion of a hib vaccine without even a trial. The vaccines have been introduced in Goa, Kerala and tamil Nadu and are being introduced in Haryana next.

The doctors said that three deaths were reported in Kerala in just three weeks and the government was continuing the programme without a pause. "When three deaths were reported in Vietnam, the country stopped the pentavalent programme," the doctors said in a letter to the Health Secretary.

Pentavalent vaccine was introduced in Kerala and Tamil Nadu on the recommendation of the National Technical Advisory Group on Immunisation (NTAGI). There were concerns about the safety of Pentavalent vaccine and therefore, the NTAGI mandated that data from the two states be reviewed after 1 year of introduction, before expanding the vaccine to other states.

"We are concerned that well before data from Kerala and Tamil Nadu was analyzed, it was introduced in Haryana at the end of last year. A death has already been reported from Haryana last week. The doctors said.

Deaths have occurred in Sri Lanka and Bhutan and Pakistan after the use of Pentavalent vaccine. In Bhutan vaccination was stopped for a year after eight deaths were reported. In Srilanka the investigation into deaths found no alternate cause for death.

Doctors said, "Deaths from Pentavalent are sporadic, meaning that thousands receive the vaccine with no reactions, but a few have died. When a drug is known to cause this form of fatal reactions, it is no longer permissible to give the medication to anyone without first testing to see if the person will react adversely. "

Doctors who signed the letter included Professor BM Hegde, Vikas Bajpai, Prof Amitav Banerjee, JP Dhadhich, Arun Gupta, K P Kushwaha  R Lodha, Prof S K Mittal, Prof Ritu Priya, Dr Jacob Puliyel, Dhiraj Shah, S Srinivasan.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 17 2013 | 5:58 PM IST

Next Story